| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702723 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
Increasing mFI scores are associated with worsening outcomes for patients undergoing RARP. A combined mFI and ASA variable can be used to predict 30-day mortality for RARP patients better than mFI or ASA alone.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Isaiah B.S., Mark B.S., Khawaja Hassan B.S., Michael M.D.,